Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 4/20 | 0.50 |
| ▸ | SLC6A4 | P31645 | 4/20 | 0.50 |
| ▸ | SLC6A3 | Q01959 | 4/20 | 0.50 |
| ▸ | CCR5 | P51681 | 1/20 | 0.48 |
| ▸ | GRM5 | P41594 | 1/20 | 0.48 |
| ▸ | GRM7 | Q14831 | 1/20 | 0.48 |
| ▸ | GRM3 | Q14832 | 1/20 | 0.48 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.48 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.48 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.48 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.48 |
| ▸ | BCHE | P06276 | 5/20 | 0.47 |
| ▸ | HRH1 | P35367 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8938288 | 1.00 | SLC6A2 (0.50) | SLC6A2SLC6A4SLC6A3CCR5GRM5 | |
| SCHEMBL9255555 | 0.90 | GRM5 (0.48) | SLC6A2SLC6A4SLC6A3GRM5GRM7 | |
| SCHEMBL8938402 | 0.89 | OPRM1 (0.51) | SLC6A2SLC6A4SLC6A3GRM5GRM7 | |
| SCHEMBL8938505 | 0.89 | OPRM1 (0.51) | SLC6A2SLC6A4SLC6A3GRM5GRM7 | |
| SCHEMBL8938240 | 0.89 | GRM5 (0.52) | SLC6A2SLC6A4SLC6A3GRM5GRM7 | |
| SCHEMBL8938444 | 0.88 | SLC6A2 (0.47) | SLC6A2SLC6A4SLC6A3GRM5GRM7 | |
| SCHEMBL8938352 | 0.85 | DRD3 (0.51) | SLC6A2SLC6A4SLC6A3CCR5GRM5 | |
| SCHEMBL8938637 | 0.85 | SIGMAR1 (0.51) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL8938360 | 0.84 | SLC6A2 (0.51) | SLC6A2SLC6A4SLC6A3GRM5GRM7 | |
| SCHEMBL8938477 | 0.84 | SLC6A2 (0.51) | SLC6A2SLC6A4SLC6A3GRM5GRM7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5534626-A | SELECTIVE MUSCARINIC RECEPTOR ANTAGONIST INTERMEDIATES | PFIZER INC. (US) | 1996-07-09 | — | — | US | disclosed |
| US-5410046-A | Selective muscarinic receptor antagonists | PFIZER INC. (US) | 1995-04-25 | — | — | US | disclosed |
| US-5231104-A | Anticholinergic | PFIZER INC. (US) | 1993-07-27 | — | — | US | disclosed |
| EP-0350309-B1 | PIPERIDINE DERIVATIVES | Pfizer Limited (GB) | 1992-11-11 | — | — | EP | disclosed |
| US-5089505-A | Anticholinergic agents | PFIZER INC. (US) | 1992-02-18 | — | — | US | disclosed |
| EP-0350309-A1 | Piperidine derivatives | Pfizer Limited (GB) | 1990-01-10 | — | — | EP | disclosed |